Clinical stage, novel technologies for managing Glaucoma
Smartlens has raised $5.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2025.
Smartlens's investors include Stanford University, 3E Bioventures, Graphene Ventures, Boutique Venture Partners, Ambit Health Ventures.
Smartlens is headquartered in Mountain View, United States.
Clinical stage, novel technologies for managing Glaucoma
Smartlens is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Smartlens — Funding & Investors." VCBacked, October 14, 2025, https://www.vcbacked.co/company/smartlens. Accessed September 30, 2026.
VCBacked. (2025). Smartlens — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/smartlens
{{cite web |title=Smartlens — Funding & Investors |url=https://www.vcbacked.co/company/smartlens |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated